TEST BANK__Primary Care: Interprofessional Collaborative Practice 7th Edition by Terry Mahan Buttaro , ISBN: 9780323935845 | All Chapters Complete (Questions with Rationalized Answers)| Guide A+

TEST BANK
Primary Care: Interprofessional Collaborative Practice

Terry Mahan Buttaro

7th Edition


All Chapters Complete (Questions with Rationalized Answers)
PR
O
FD
O
C

, Table of Contents
Part 1: Introduction
1. Interprofessional Collaborative Practice: Where We Are Today
2. Translating Evidence into Clinical Practice
3. Empowering Patients as Collaborative Partners: A New Model for Primary Care
4. Coordinated Chronic Care
5. Promoting Health Equity and Overcoming Health Disparities
6. Patient/Family Education and Health Literacy
7. Genetic Considerations in Primary Care
8. Risk Management
9. Endocannabinoids in Primary Care
10. Self-Care

Part 2: Primary Care: Adolescence Through Adulthood
PR
11. Adolescent Issues
12. Care of LGBTQ+ People
13. Pregnancy, Prenatal Care, and Lactation
14. Human Trafficking
15. Aging and Common Geriatric Syndromes
16. Palliative Care
O
17. Acute, Chronic, Oncologic, and End-of-Life Pain Management in Primary Care
FD
Part 3: Health Promotion
18. Rewilding Wellness: An Integrated Perspective
19. Obesity and Weight Management
20. Principles of Occupational and Environmental Health in Primary Care
21. Public Health Preparedness in Primary Care
22. College Health
O
23. Presurgical Risk Assessment and Evaluation
24. Preparticipation Sports Physical
C
Part 4: Emergent Care
25. Acute Bronchospasm
26. Anaphylaxis
27. Bites and Stings
28. Bradycardia and Tachycardia
29. Chemical and Electrical Injuries
30. Environmental and Food Allergies
31. Head Trauma
32. Hypotension
33. Poisoning
34. Sexual Assault
35. Syncope
36. Thermal Injuries

Part 5: Evaluation and Management of Skin Disorders
37. Examination of the Skin and Approach to Diagnosis of Skin Disorders

,38. Surgical Office Procedures
39. Principles of Dermatologic Therapy
40. Screening for Skin Cancer
41. Adnexal Disease
42. Alopecia
43. Animal and Human Bites
44. Benign Skin Lesions
45. Bullous Pemphigoid
46. Burns (Minor)
47. Cutaneous Adverse Drug Reactions
48. Eczematous Dermatitis
49. Infections and Infestations
50. Nail Disorders
51. Maculopapular Skin Disorders
PR
52. Pigmentation Changes
53. Wound Management

Part 6: Evaluation and Management of Eye Disorders
54. Evaluation of the Eyes
55. Cataracts
O
56. Blepharitis, Hordeolum, and Chalazion
57. Conjunctivitis
58. Corneal Surface Defects and Ocular Surface Foreign Bodies
FD
59. Dry Eye Syndrome
60. Nasolacrimal Duct Obstruction and Dacryocystitis
61. Preseptal and Orbital Cellulitis
62. Pingueculae and Pterygia
63. Traumatic Ocular Disorders
O

Part 7: Evaluation and Management of Ear Disorders
64. Auricular Disorders
C
65. Cerumen Impaction
66. Cholesteatoma
67. Impaired Hearing
68. Inner Ear Disturbances
69. Otitis Externa
70. Otitis Media
71. Tympanic Membrane Perforation

Part 8: Evaluation and Management of Nose Disorders
72. Chronic Nasal Congestion and Discharge
73. Epistaxis
74. Nasal Trauma
75. Rhinitis
76. Sinusitis
77. Smell and Taste Disturbances
78. Tumors and Polyps of the Nose

, Part 9: Evaluation and Management of Oropharynx Disorders
79. Dental Abscess
80. Diseases of the Salivary Glands
81. Epiglottitis
82. Oral Infections
83. Parotitis
84. Pharyngitis and Tonsillitis
85. Peritonsillar Abscess

Part 10: Evaluation and Management of Pulmonary Disorders
86. Acute Bronchitis
87. Asthma
88. Chest Pain (Noncardiac)
PR
89. Chronic Cough
90. Chronic Obstructive Pulmonary Disease
91. Dyspnea
92. Hemoptysis
93. Lung Cancer
94. Pleural Effusions and Pleurisy
O
95. Pneumonia
96. Pneumothorax
97. Pulmonary Embolism
FD
98. Pulmonary Hypertension
99. Sarcoidosis

Part 11: Evaluation and Management of Cardiovascular Disorders
100. Cardiac Diagnostic Testing: Noninvasive Assessment of Coronary Artery Disease
O
101. Abdominal Aortic Aneurysm
102. Cardiac Arrhythmias
103. Carotid Artery Disease
C
104. Coronary Artery Disease and Chest Pain
105. Heart Failure
106. Hypertension
107. Infective Endocarditis
108. Myocarditis
109. Peripheral Arterial and Venous Insufficiency
110. Valvular Heart Disease and Cardiac Murmurs

Part 12: Evaluation and Management of Gastrointestinal Disorders
111. Abdominal Pain and Infections
112. Anorectal Complaints
113. Cholelithiasis and Cholecystitis
114. Cirrhosis
115. Constipation
116. Diarrhea
117. Dyspepsia

,118. Gastroesophageal Reflux Disease
119. Gastrointestinal Bleeding
120. Hepatitis
121. Inflammatory Bowel Disease
122. Irritable Bowel Syndrome
123. Pancreatitis
124. Peptic Ulcer Disease

Part 13: Evaluation and Management of Genitourinary Disorders
125. Acute Kidney Injury
126. Benign Prostatic Hyperplasia
127. Chronic Kidney Disease
128. Erectile Dysfunction
129. Hematuria
PR
130. Nephrolithiasis
131. Prostatitis
132. Sexually Transmitted Infections
133. Urinary Incontinence
134. Urinary Tract Infection
O
Part 14: Evaluation and Management of Gynecologic Concerns
135. Abnormal Uterine Bleeding
136. Cervical Dysplasia and Cancer Screening
FD
137. Endometriosis
138. Infertility
139. Menopause
140. Ovarian Disorders
141. Pelvic Inflammatory Disease
O
142. Vaginitis

Part 15: Evaluation and Management of Musculoskeletal and Arthritic Disorders
C
143. Back Pain
144. Bursitis
145. Carpal Tunnel Syndrome
146. Fibromyalgia
147. Gout
148. Osteoarthritis
149. Osteoporosis
150. Tendinitis

Part 16: Evaluation and Management of Neurologic Disorders
173. Amyotrophic Lateral Sclerosis
174. Bell's Palsy
175. Cerebrovascular Events
176. Dementia
177. Dizziness and Vertigo
178. Guillain-Barré Syndrome

,179. Headache
180. Infections of the Central Nervous System
181. Movement Disorders and Essential Tremor
182. Multiple Sclerosis
183. Parkinson Disease
184. Seizure Disorder
185. Trigeminal Neuralgia
186. Intracranial Tumors

Part 17: Evaluation and Management of Endocrine and Metabolic Disorders
187. Adrenal Gland Disorders
188. Diabetes Mellitus
189. Hirsutism
190. Hypercalcemia and Hypocalcemia
PR
191. Hyperkalemia and Hypokalemia
192. Hypernatremia and Hyponatremia
193. Lipid Disorders
194. Metabolic Syndrome
195. Parathyroid Gland Disorders
196. Thyroid Disorders
O

Part 18: Evaluation and Management of Rheumatic Disorders
197. Polymyalgia Rheumatica and Giant Cell Arteritis
FD
198. Raynaud Phenomenon
199. Rheumatoid Arthritis
200. Seronegative Spondyloarthropathies
201. Systemic Lupus Erythematosus
202. Vasculitis
O

Part 19: Evaluation and Management of Multisystem Disorders
203. Diving-Related Maladies
C
204. Fatigue
205. Fever
206. Immunodeficiency
207. Lymphadenopathy
208. Sleep Disorders
209. Unintended Weight Loss

Part 20: Evaluation and Management of Infectious Diseases
210. Emerging and Reemerging Infectious Diseases
211. HIV Infection
212. Influenza
213. Infectious Diarrhea
214. Infectious Mononucleosis
215. Tick-Borne Diseases
216. Tuberculosis
217. Mosquito-Borne Illnesses

, Part 21: Evaluation and Management of Hematologic Disorders
218. Anemia
219. Blood Coagulation Disorders
220. Leukemias
221. Lymphomas
222. Myelodysplastic Syndromes

Part 22: Evaluation and Management of Oncologic Disorders
223. Interprofessional Collaborative Management of the Oncology Patient
224. Basic Principles of Oncology Treatment
225. Oncology Complications, Paraneoplastic Syndromes, and Cancer Survivorship

Part 23: Evaluation and Management of Mental Health Disorders
PR
226. Anxiety Disorders
227. Bipolar Disorder
228. Depression
229. Eating Disorders
230. Personality Disorders
231. Schizophrenia and Psychotic Disorders
O
232. Somatic Symptom Disorders
233. Substance Use Disorders
FD
O
C

,Chapter 01: Interprofessional Collaborative Practice: Where We Are Today

MULTIPLE CHOICE

1. A small, rural hospital is part of an Accountable Care Organization (ACO) and is designated
as a Level 1 ACO. What is part of this designation?
a. Bonuses based on achievement of benchmarks
b. Care coordination for chronic diseases
c. Standards for minimum cash reserves
d. Strict requirements for financial reporting
ANS: A
A Level 1 ACO has the least amount of financial risk and requirements, but receives shared
savings bonuses based on achievement of benchmarks for quality measures and
expenditures. Care coordination and minimum cash reserves standards are part of Level 2
PR
ACO requirements. Level 3 ACOs have strict requirements for financial reporting.

2. What was an important finding of the Advisory Board survey of 2014 about primary care
preferences of patients?
a. Associations with area hospitals
b. Costs of ambulatory care
O
c. Ease of access to care
d. The ratio of providers to patients
ANS: C
FD
As part of the 2014 survey, the Advisory Board learned that patients desired 24/7 access to
care, walk-in settings and the ability to be seen within 30 minutes, and care that is close to
home. Associations with hospitals, costs of care, and the ratio of providers to patients were
not part of these results.
O
MULTIPLE RESPONSE
C

,1. Which assessments of care providers are performed as part of the value-based purchasing
(VBP) initiative? (Select all that apply.)
a. Appraising costs per case of care for Medicare patients
b. Assessing patients’ satisfaction with hospital care
c. Evaluating available evidence to guide clinical care guidelines
d. Monitoring mortality rates of all patients with pneumonia
e. Requiring advanced IT standards and minimum cash reserves
ANS: A, B, D
Value-based purchasing looks at five domain areas of processes of care, including efficiency
of care (cost per case), experience of care (patient satisfaction measures), and outcomes of
care (mortality rates for certain conditions). Evaluation of evidence to guide clinical care is
part of evidence-based practice. The requirements for IT standards and financial status are
part of Accountable Care Organization standards.
PR
O
FD
O
C

, Chapter 02: Translating Research into Clinical Practice
MULTIPLE CHOICE

1. What is the purpose of Level II research?
a. To define characteristics of interest of groups of patients
b. To demonstrate the effectiveness of an intervention or treatment
c. To describe relationships among characteristics or variables
d. To evaluate the nature of relationships between two variables
ANS: C
Level II research is concerned with describing the relationships among characteristics or
variables. Level I research is conducted to define the characteristics of groups of patients.
Level II research evaluates the nature of the relationships between variables. Level IV
research is conducted to demonstrate the effectiveness of interventions or treatments.
PR
2. Which is the most appropriate research design for a Level III research study?
a. Epidemiological studies
b. Experimental design
c. Qualitative studies
d. Randomized clinical trials
O
ANS: B
The experimental design is the most appropriate design for a Level III study.
Epidemiological studies are aNpU
p rRopSrI
iaN
teGfT
orBL.eC
v eOl MI I studies. Qualitative designs are useful
FD
for Level I studies. Randomized clinical trials are used for Level IV studies.

3. What is the purpose of clinical research trials in the spectrum of translational research?
a. Adoption of interventions and clinical practices into routine clinical care
b. Determination of the basis of disease and various treatment options
c. Examination of safety and effectiveness of various interventions
O
d. Exploration of fundamental mechanisms of biology, disease, or behavior
ANS: C
Clinical research trials are concerned with determining the safety and effectiveness of
C
interventions. Adoption of interventions and practices is part of clinical implementation.
Determination of the basis of disease and treatment options is part of the preclinical research
phase. Exploration of the fundamental mechanisms of biology, disease, or behavior is part
of the basic research stage.